Several reports in Crohn’s disease (CD) and ulcerative colitis (UC) patients indicate disruption of GM-CSF signaling due to increased circulating or local levels of anti-GM-CSF autoantibodies [108,109,110], downregulation of CD116 [111] or inactivating mutations of βc [112,113]. Here, CSF2 is linked to Crohn disease.